# Corticoid Therapy in Acute Myocarditis

> **NCT06522100** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 420 (estimated)

## Conditions studied

- Acute Myocarditis

## Interventions

- **DRUG:** Intravenous administration of Methylprednisolone
- **DRUG:** Oral Prednisone
- **DRUG:** Perfusion of placebo
- **DRUG:** Oral Prednisone placebo

## Key facts

- **NCT ID:** NCT06522100
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2028-08-16
- **Final completion:** 2028-08-16
- **Target enrollment:** 420 (ESTIMATED)
- **Last updated:** 2024-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06522100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06522100, "Corticoid Therapy in Acute Myocarditis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06522100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*